AMP vs MSCI

AMP's deterministic health score is weak with a Piotroski F-Score of 4/9, indicating borderline financial stability. Despite strong profitability metrics like a 59.59% ROE and solid earnings growth (YoY +86.6%), the stock trades above its Graham defensive value of $235.33 at $496.60, reflecting rich valuation. Earnings volatility, declining recent estimate beats, and bearish insider activity offset strong cash flow efficiency and low leverage. Analysts concur with a 'hold' rating, aligning with technical bearishness and mixed fundamentals.

MSCI presents a compelling growth-at-a-quality story, trading at a premium valuation justified by best-in-class profitability and consistent earnings outperformance. Despite near-term price weakness (-5.3% over 1Y), the stock has delivered strong 5Y returns (+49.6%) on the back of durable double-digit earnings growth (19% YoY) and industry-leading margins. The company significantly outperforms its financial services peers in profitability and growth, with an operating margin of 56.43% and revenue growth of 9.5%, versus sector averages of 24.91% and 21.31% respectively. Analysts are aligned with a 'buy' consensus and a $655.06 target price, implying 15.9% upside, while insider selling remains a minor counterpoint.